About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,820 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,820 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4421-4440 of 10,820 trials

CompletedEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE have ongoing disease…NCT04058028·Birmingham, Alabama and 146 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedStudy of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseThe goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and…NCT00105300·Huntsville, Alabama and 55 others

CompletedA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsThis is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid…NCT02403271·Birmingham, Alabama and 16 others

RecruitingA Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple MyelomaThe purpose of this study is to evaluate the safety and tolerability of mRNA-2808 in participants with relapsed or refractory multiple myeloma (RRMM).NCT07116616·Birmingham, Alabama and 9 others

Active not recruitingA Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSThe goal of the VNS4PWS clinical study is to test the efficacy, safety, and acceptability of transcutaneous vagus nerve stimulation (tVNS) treatment in people with PWS.NCT06144645·Palo Alto, California and 17 others

TerminatedStudy of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II AchalasiaThe objectives of this study are as follows: In participants with primary Type I or II achalasia, following a single 5-mg dose of olinciguat (IW-1701), * To assess the safety…NCT02931565·Bristol, Connecticut and 4 others

TerminatedLoss of Effect of Aspirin on Platelet Aggregation During Chronic AdministrationAspirin has shown to be beneficial to some patients with certain diseases such as coronary artery disease or stroke.NCT00748371·Nashville, Tennessee

RecruitingA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell…NCT06330064·Los Angeles, California and 119 others

CompletedInvestigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1A randomized, placebo-controlled, double-blind, parallel group, multi center study to assess the safety and efficacy of tiotropium bromide (18 µg) delivered via the HandiHaler® in…NCT01663987·Birmingham, Alabama and 49 others

RecruitingReducing Overuse of Antibiotics With Decision SupportEliminating inappropriate antibiotic use in pediatric lower respiratory tract infections (LRTI) is the central focus of this research.NCT06788093·Oakland, California and 2 others

CompletedAn Observational Study of the Functional Capacity of Heart FailureThis is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine…NCT02350114·Indianapolis, Indiana and 5 others

CompletedPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachThis study is a Phase I/II trial of Tivantinib plus FOLFOX for the treatment of patients with advanced solid tumors.NCT01611857·New Haven, Connecticut and 8 others

TerminatedEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaThe primary objective of this study is to compare the additive efficacy of SIM versus placebo in combination with leucovorin (folinic acid), irinotecan, and fluorouracil (FOLFIRI)…NCT01479465·Huntsville, Alabama and 108 others

CompletedEfficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With PacemakersThe purpose of this study is to determine the safety and efficacy of an investigational antiarrhythmic drug (ATI-2042) in the treatment of atrial fibrillation in patients with a…NCT00389792·Phoenix, Arizona and 39 others

CompletedA Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisThis study will assess the efficacy and safety of subcutaneous Mircera in the treatment of renal anemia in patients with chronic kidney disease who are not on dialysis and not…NCT00081471·Los Angeles, California and 97 others

CompletedAxitinib Given on an Individualized Schedule for Metastatic Renal Cell CancerAxitinib is a drug which is approved by the FDA for patients with advanced kidney cancer who have already received some treatment. It works by reducing blood flow to a tumor.NCT02579811·Duarte, California and 3 others

CompletedChemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003298·Denver, Colorado and 29 others

TerminatedFirst-in-Human Study of TAK-280 in Participants With Solid TumorsThe main aim of this study is to find out the safety, tolerability, and effect of TAK- 280 in participants with unresectable, locally advanced or metastatic cancer who have…NCT05220098·Little Rock, Arkansas and 22 others

CompletedAlternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic SyndromesThe purpose of this study is to determine if azacitidine, combined with Best Supportive Care (BSC), is effective in treating myelodysplastic syndromes (MDS) when given according…NCT00102687·Bakersfield, California and 30 others

CompletedSorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma PatientsThis is a single-arm Phase I/II study of sorafenib and bortezomib with dose optimization in initial patients.NCT00536575·Bethesda, Maryland and 1 other

PreviousPage 222 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville